High-dose cyclophosphamide in refractory myasthenia gravis with MuSK antibodies

被引：29

作者：

Lin, PT

Martin, BA

Weinacker, AB

So, YT ^{[1
]}

机构：

[1] Stanford Univ, Dept Neurol & Neurol Sci, Stanford, CA 94305 USA

[2] Stanford Univ, Dept Med, Div Hematol, Stanford, CA 94305 USA

[3] Stanford Univ, Dept Med, Div Pulm & Crit Care, Stanford, CA 94305 USA

来源：

MUSCLE & NERVE | 2006年 / 33卷 / 03期

关键词：

cyclophosphamide; mmune-system rebooting; muscle-specific tyrosine kinase; MuSK antibody; myasthenia gravis; seronegative;

D O I：

10.1002/mus.20411

中图分类号：

R74 [神经病学与精神病学];

学科分类号：

摘要：

We describe a 48-year-old woman with seronegative myasthenia gravis (MG) and high-titer of anti-MuSK antibody. She had severe bulbar and respiratory weakness with minimal limb weakness for 2 years. Her disease responded poorly to all the conventional immunosuppressive regimens. Treatment with immunoablative dose of cyclophosphamide led to dramatic and sustained remission of her symptoms. High-dose cyclophosphamide is an effective alternative in patients with unusually refractory disease.

引用

收藏

页码：433 / 435

页数：3

相关论文

共 20 条

[11] Detection and characterization of MuSK antibodies in seronegative myasthenia gravis [J].

McConville, J ;

Farrugia, ME ;

Beeson, D ;

Kishore, U ;

Metcalfe, R ;

Newsom-Davis, J ;

Vincent, A .

ANNALS OF NEUROLOGY, 2004, 55 (04) :580-584

[12]

Müller-Hermelink HK, 1999, ANN MED, V31, P5

[13] Clinical aspects of MuSK antibody positive seronegative MG [J].

Sanders, DB ;

El-Salem, K ;

Massey, JM ;

McConville, J ;

Vincent, A .

NEUROLOGY, 2003, 60 (12) :1978-1980

[14]

SANDERS DB, 1978, NEUROLOGY, V28, P266

[15] Are MuSK antibodies the primary cause of myasthenic symptoms? [J].

Selcen, D ;

Fukuda, T ;

Shen, XM ;

Engel, AG .

NEUROLOGY, 2004, 62 (11) :1945-1950

[16] Acetylcholine receptors loss and postsynaptic damage in MuSK antibody-positive myasthenia gravis [J].

Shiraishi, H ;

Motomura, M ;

Yoshimura, T ;

Fukudome, T ;

Fukuda, T ;

Nakao, Y ;

Tsujihata, M ;

Vincent, A ;

Eguchi, K .

ANNALS OF NEUROLOGY, 2005, 57 (02) :289-293

[17] Seronegative generalised myasthenia gravis: clinical features, antibodies, and their targets [J].

Vincent, A ;

Bowen, J ;

Newsom-Davis, J ;

McConville, J .

LANCET NEUROLOGY, 2003, 2 (02) :99-106

[18] Seronegative myasthenia gravis [J].

Vincent, A ;

McConville, J ;

Farrugia, ME ;

Newsom-Davis, J .

SEMINARS IN NEUROLOGY, 2004, 24 (01) :125-133

[19] Low frequency of MuSK antibody in generalized seronegative myasthenia gravis among Chinese [J].

Yeh, JH ;

Chen, WH ;

Chiu, HC ;

Vincent, A .

NEUROLOGY, 2004, 62 (11) :2131-2132

[20] Clinical comparison of muscle-specific tyrosine kinase (MuSK) antibody-positive and -negative myasthenic patients [J].

Zhou, L ;

McConville, J ;

Chaudhry, V ;

Adams, RN ;

Skolasky, RL ;

Vincent, A ;

Drachman, DB .

MUSCLE & NERVE, 2004, 30 (01) :55-60